- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04072536
Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving (SWADAPT1)
Evaluation on Standardized Circuits of the Interest of a Robotic Module of Assistance to the Driving of Patients With Neurological Disorders, Regular Drivers of Electric Wheelchairs.
Study Overview
Status
Conditions
Detailed Description
The device that is the subject of this investigation is a robotic assistance module for driving a semi-autonomous electric wheelchair. This module is designed to accessorize the electric wheelchair to improve the safety conditions when driving an electric wheelchair, thus reducing the wheelchair accident rate on the one hand and facilitating access to the wheelchair to persons who can not claim it without the use of a safety device of this type.
Each patient included will test a wheelchair equipped with a collision avoidance assistance module in 2 conditions, assistance activated or not. This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart. At each session, the patient will perform the circuit 6 times, including 3 with activated assistance, in a random order established upstream.
Study Type
Enrollment (Actual)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Bretagne
-
Rennes, Bretagne, France, 35000
- Pôle Saint-Hélier
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Description
Inclusion Criteria:
- Aged over 18,
- Having freely consented to participate in the study,
- suffering from neurological disorders such as cerebro-lesion or neuro-degeneration,
- Having benefited from a prescription of electric wheelchair and circulating in an electric wheelchair for more than 3 months,
- of which the electric wheelchair is the main mode of transport,
- The physical measurements (weight, height) are compatible with the use of the electric wheelchair chosen for the development of the robotics assistance module.
Exclusion Criteria:
- Understanding difficulties preventing the realization of the protocol,
- Motor disorders of the upper limb requiring additional driving technical assistance,
- Patient having expressed difficulties impacting his safety of sedan and / or exterior.
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: Randomized
- Interventional Model: Crossover Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Electric wheelchair with activated assistance module
This condition will be achieved in 3 standardized test circuits of increasing difficulty, one week apart.
At each session, the patient will perform the circuit 6 times, including 3 with activated assistance, in a random order established upstream.
|
This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart.
At each session, the patient will perform the circuit 6 times, including 3 with activated assistance
|
|
Other: Electric wheelchair with assistance module not activated
This condition will be achieved in 3 standardized test circuits of increasing difficulty, one week apart.
At each session, the patient will perform the circuit 6 times, including 3 without activated assistance, in a random order established upstream.
|
This evaluation will be carried out in 3 standardized test circuits of increasing difficulty, one week apart.
At each session, the patient will perform the circuit 6 times, including 3 with no activated assistance
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Number of collision
Time Frame: Day 1
|
The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module.
|
Day 1
|
|
Number of collision
Time Frame: Day 8
|
The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module.
|
Day 8
|
|
Number of collision
Time Frame: Day 15
|
The primary judgment criterion is the number of collisions on different standardized circuits with and without activation of the robotic assistance module.
|
Day 15
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
NASA-Task Load Index
Time Frame: Day 1, Day 8 and Day 15
|
The cognitive load of tests under both conditions will be measured by the NASA-Task Load Index.
It is in the form of six scales where the participant must assign a score between zero and one hundred to each of them, score indicating a growing level of intensity.
Three dimensions relate to the demands imposed on the subject (mental, physical and temporal demands) and three to the interaction of a subject with the task (effort, frustration and performance)
|
Day 1, Day 8 and Day 15
|
|
Ease of Use Questionnaire
Time Frame: Day 1, Day 8 and Day 15
|
The satisfaction of the use of the electric wheelchair under the conditions will be evaluated by the self-questionnaire Ease of Use Questionnaire.
It measures the subjective usability of a product or service.
It is a 30-item survey that examines four dimensions of usability: usefulness, ease of use, ease of learning, and satisfaction.
The questionnaires were constructed as seven-point Likert rating scales.
Users were asked to rate agreement with the statements, ranging from strongly disagree (1) to strongly agree (7).
|
Day 1, Day 8 and Day 15
|
|
Driving Speed
Time Frame: Day 1, Day 8 and Day 15
|
Speed measured by the completion time of the course with and without activation of the assistance system on the different circuits
|
Day 1, Day 8 and Day 15
|
|
Wheelchair Skill Test
Time Frame: Day 1, Day 8 and Day 15
|
Driving performance measured by the Wheelchair Skill Test items corresponding to the different courses, with and without activation of the assistance system
|
Day 1, Day 8 and Day 15
|
|
UTAUT (Unified theory of acceptance of technology) questionnaire
Time Frame: Day 1, Day 8 and Day 15
|
Questionnaire of acceptability / acceptance of the tool and its use by patients based on the Unified Theory of Acceptance and Use Technology (UTAUT).
|
Day 1, Day 8 and Day 15
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 2019-A00476-51
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Neurological Disorders
-
University of LeedsThe Royal College of Surgeons of EnglandCompletedSurgery | Surgery--Complications | Outcome, Fatal | Neurological Disorder | Morality | Neurological Morbidity | Neurological Complication | Comorbidities and Coexisting Conditions | Neurological Diseases or Conditions | Neurological Procedural Complication
-
Damanhour UniversityMansoura UniversityCompletedNeurological Disorders
-
Wayne State UniversityCompletedNeurological DisordersUnited States
-
South West London and St George's Mental Health...CompletedFunctional Neurological Symptom DisorderUnited Kingdom
-
University of FloridaNational Science FoundationCompleted
-
National Center for Complementary and Integrative...CompletedNeurological DisordersUnited States
-
University of FribourgInsel Gruppe AG, University Hospital BernCompletedFunctional Neurological Symptom Disorder | Neurological Diseases or ConditionsSwitzerland
-
Innodem NeurosciencesTerminatedNeurological DisordersCanada
-
Fondation Ophtalmologique Adolphe de RothschildActive, not recruitingFunctional Neurological DisordersFrance
-
University of Colorado, DenverRecruitingFunctional Neurological DisorderCanada
Clinical Trials on Electric wheelchair with activated assistance module
-
Pôle Saint HélierINSA RennesCompleted
-
Pôle Saint HélierINSA RennesCompletedNeurological DisorderFrance
-
VA Office of Research and DevelopmentCompletedBlindness | Spinal Cord InjuryUnited States